Grey Market Premium (GMP) – Simple Guide for Indian IPO Investors
Ever see a headline saying an IPO has a "+₹150 GMP" and wonder what that means? It’s the market’s early guess on how much investors are willing to pay above the offer price. In India, the grey market is where traders buy and sell IPO shares before they officially list. The price difference they quote is called the Grey Market Premium, or GMP.
GMP isn’t official data from the stock exchanges. It’s just the price that a handful of brokers, dealers, and high‑net‑worth investors are willing to pay in the underground market. Because it’s based on real money changing hands, many people treat it as a quick pulse check on demand for a new stock.
How GMP Is Calculated
To get the GMP number, a broker looks at the price at which an investor buys a share in the grey market and subtracts the IPO’s issue price. If the issue price is ₹500 and someone pays ₹620 in the grey market, the GMP is ₹120. Some sites show GMP as a percentage, but most Indian reports stick to the absolute rupee amount.
The number can swing a lot in the days leading up to the listing. A strong GMP suggests that investors expect the stock to jump once it starts trading. A negative or low GMP means the market thinks the IPO might be overpriced or that demand is weak.
What Investors Should Watch Out For
Even though GMP can be a useful hint, it’s not a guarantee. Many IPOs with high GMP end up flat or even falling after the first day. The reason is simple: GMP reflects expectations, not actual performance. Market sentiment can change in minutes, especially after the opening bell when real trading volume shows up.
Another caution: the grey market is not regulated like the main exchanges. Transactions happen off‑record, so there’s less transparency. Always double‑check any GMP figure you see and consider the source. A reputable brokerage or a well‑known financial portal is safer than a random social‑media post.
For long‑term investors, GMP should be just one tool among many. Look at the company’s fundamentals, business model, and growth plans. If the GMP is high but the company’s earnings are shaky, you might be buying hype rather than value.
Finally, remember that buying in the grey market is not the same as buying on the stock exchange. You can’t sell those shares until the IPO lists, and you might have to pay a premium upfront. If you’re not comfortable with that risk, it’s better to wait for the official trading day.
In short, Grey Market Premium gives you a quick snapshot of how the market feels about a new stock. Use it to gauge interest, but blend it with solid research before you decide whether to invest. That way you avoid getting caught in a hype wave that crashes as fast as it rose.
Anthem Biosciences IPO: ₹3,395 Crore Offer Draws Massive Investor Interest Ahead of July 21 Listing
Anthem Biosciences' ₹3,395 crore IPO, running from July 14–16, 2025, sparked huge investor interest, booking nearly 10 times the available shares. The Bengaluru CRDMO sets a price band at ₹540–₹570, with anchor investors like Abu Dhabi Investment Authority. Grey market sentiment suggests listing gains for the July 21 debut.